Women's cancer

Leading experts from centres of excellence have developed this suite of educational programmes to support your clinical decision-making.

CONNECTs

Our programmes

See All
Podcast
Experts knowledge share
E-learning
Video
Publication
Other

Oncology

An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition

Experts

Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr Shinji Ohno, Dr Rebecca Dent, Prof. Charlie Gourley

Downloadable
Resources
60 MIN
Sep 2021

Non-accredited Independent Medical Education

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Video

Oncology

Understand the MoA of PARP inhibitors and targeting DNA Damage Response (DDR)

Experts

Dr Robert L. Coleman, Prof. Simon Boulton

Downloadable
Resources
5 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Oncology

Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy

Experts

Dr Judith Balmaña, Dr Rebecca Dent, Prof. Simon Boulton, Prof. Sibylle Loibl, Prof. Eric Pujade-Lauraine, Prof. Charlie Gourley, Dr Violeta Serra, Prof. Jonathan A. Ledermann

Downloadable
Resources
10 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Interactive e-learning

Oncology

The Role of PARP Inhibition in Clinical Practice

Experts

Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine

60 MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Other

Oncology

The Role of DDR and PARP inhibition (PARPi) in Oncology – BluePrints

Experts

Dr Violeta Serra, Prof. Jonathan A. Ledermann, Prof. Eric Pujade-Lauraine, Prof. Simon Boulton, Dr Mark J. O'Connor, Prof. Charlie Gourley, Dr Judith Balmaña, Prof. Sibylle Loibl

Downloadable
Resources
MIN
Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Oncology

PARP inhibition and DNA Damage Response (DDR)

This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types

Experts

Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley

30 MIN
Oct 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca

Oncology

COR2ED at ESMO 2022

We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.

2 MIN
Sep 2022

Oncology

Update From San Antonio Breast Cancer Symposium 2022

COR2ED presents an update on selected General Sessions from SABCS 2022

Experts

Dr Santiago Escrivá de Romaní

5 MIN
Dec 2022

Podcast

Episode

1

of 2

Oncology Obstetrics and Gynecology

Systemic Therapies in Endometrial Carcinoma

The physicians' perspective

Experts

Dr Domenica Lorusso, Dr Mansoor Raza Mirza, Andreia Fernandes, Jo Pearson

Endorsed by

Downloadable
Resources
MIN
Feb 2023

Educational programme supported by an Independent Educational Grant from Eisai Europe Ltd.

Conference update

Episode

1

of 6

Oncology

Listen to Expert Insights on Late-Breaking Data from ASCO 2023

Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial

Experts

Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager

2 MIN
Jun 2023

Video

Episode

1

of 4

Oncology

New Oral Endocrine Therapy Options for Patients with Advanced or Metastatic ER+ Breast Cancer

Episode 1: Overview of Clinical Data of SERDs & Their Place in Treatment Landscape

Experts

Dr Sara Tolaney, Dr Aditya Bardia, Prof. Frédérique Penault-Llorca

Endorsed by

Downloadable
Resources
18 MIN
Jul 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Podcast

Episode

1

of 3

Oncology

Oral SERDs in ER+ breast cancer

Episode 1: Efficacy, safety and treatment landscape

Experts

Prof. Shaheenah Dawood, Assoc. Clinical Professor Rena Callahan

Endorsed by

MIN
Jul 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Interactive patient case

Episode

1

of 2

Oncology

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 1

An interactive patient case video series from breast cancer specialists

Experts

Dr Elisa Agostinetto

Endorsed by

15 MIN
Sep 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Video

Oncology

Navigating the ER+ Breast Cancer Journey: Oral SERDs and the Treatment Landscape

Follow a patient's breast cancer journey from diagnosis to treatment options

Experts

Prof. Francois-Clement Bidard

Endorsed by

Downloadable
Resources
7 MIN
Oct 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.

Interactive patient case

Episode

2

of 2

Oncology

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer – Part 2

An interactive patient case video series from breast cancer specialists

Experts

Prof. Valentina Guarneri

Endorsed by

15 MIN
Oct 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Tweetorial

Oncology

Tweetorial video: Navigating ER+ metastatic breast cancer

Explore a patient case from testing, diagnosis and treatment

Experts

Dr Paolo Tarantino

Endorsed by

9 MIN
Nov 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology

Video

Oncology

Actionable fusions in solid tumours

An overview of gene fusions, gold standard detection methods and treatment implications

Experts

Prof. Fernando López-Ríos

Downloadable
Resources
3 MIN
Dec 2023

Educational programme supported by an Independent Educational Grant from Bayer.

Video

Oncology

ER+ metastatic breast cancer: Elacestrant and beyond

Follow a patient's journey during and post-elacestrant treatment for ER+/HER2- metastatic breast cancer

Experts

Prof. Maria Vittoria Dieci

Endorsed by

Downloadable
Resources
5 MIN
Feb 2024

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.

Conference update

Episode

2

of 4

Oncology

ASCO 2024 breast cancer highlights

How could the data impact clinical practice?

Experts

Prof. Shaheenah Dawood

3 MIN
Jun 2024

Conference update

Oncology

ESMO 2024: New data on GI, lung, HCC, breast and GU cancers

Renowned medical experts share their insights into new data presented at ESMO 2024

Downloadable
Resources
5 MIN
Sep 2024

Explore all programmes

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.